Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × Hydroxyurea × Clear all

Sponsor

Conditions

Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Meningioma 3 Glioblastoma 3 Polycythemia Vera 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Gliosarcoma 2 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Nose Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Glioma 1 Epstein-Barr Virus Infections 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡